A TRPV1 antagonist (IC50 = 1.4 μM); has antinociceptive effects and reduces hyperalgesia and edemia at a dose of 0.3 μmol/kg; increases the seizure threshold; reduces depressive-like behavior in mice; has anti-inflammatory activity; inhibits benign prostatic hyperplasia in rats,